Close Menu

Heating Up

The Boston Globe notes a recent spike in biotech merger and acquisitions. The deals going through at Inverness, Biogen, and Takeda follow an 18-month-long lull. "When you've had a cycle of fear and now we're seeing real signs that growth is coming," says Kevin Gorman from Putnam Associates, "if you can pick up an asset that fits your strategy, and you can pick it up at a decent price, why not?"

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Financial Times reports the US bolstering its ability to track SARS-CoV-2 alterations.

The New York Times reports that Cedars-Sinai researchers have uncovered a new strain of SARS-CoV-2 in Southern California.

In Nucleic Acids Research this week: pan-cancer atlas focus on miRNA biogenesis mutations, methylation analysis of pig skeletal muscles, and more.

President-elect Joe Biden has nominated Eric Lander to serve as director of the Office of Science and Technology Policy, the Associated Press says.